Summary:
Supplementation with ω3 fatty acids appears to offer benefits
that are verifiable at a biochemical, clinical and functional level.
Related literature, however, provides conflicting results; therefore
further studies will be required to confirm their efficacy.
Supplementation with glutamine appears to support the efficacy of
chemoradiotherapy treatment while reducing toxicity of the tissues and
improving outcomes. Oral supplementation with branched amino acid
appears to reduce the length of hospital stay, decrease morbidity and
improve the quality of life, without any changes in mortality.
Perioperative supplementation with arginine has shown a reduced
incidence of complications and a significant increase in long-term
survival.
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.